RxDoctor Payments Data

Natasha Romanoski, DO

Physical Medicine & Rehabilitation · Hummelstown, PANPI 1780959429

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $3,608 of the $4,605 with a category attached, or 78.3%. 9 manufacturers reported payments, led by AbbVie at 55.7% of the total. Reporting peaked in 2024 at $2,262 and has fallen 85.1% since, to $337 in 2025. Among physical medicine & rehabilitation clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,605in general payments, 2019–2025

Across 22 payments — averaging $209.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Ipsen Biopharmaceuticals, Inc$1K
  • Merz Pharmaceuticals, LLC$218
  • Sanofi$110
  • Medtronic$80
  • Merz North America, Inc.$72
  • plus $117 from 3 others
$133,931in research payments, 2019–2025

Across 177 payments — averaging $756.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Ipsen Pharma SAS$134K

What the payments were for

  • Consulting fees$3,60878%
  • Food & beverage$99822%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,605 in reported general payments places this provider in the 90th percentile of 550 physical medicine & rehabilitation providers in Pennsylvania.

See all physical medicine & rehabilitation providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$51,397
Medicare patients
223
Services billed
714

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Baclofen214$6,075
OxycontinOxycodone Hcl14$4,021
Gabapentin64$1,101
Tizanidine Hcl111$1,051
Pregabalin71$908
Darifenacin ErDarifenacin Hydrobromide12$778
Duloxetine Hcl28$472
Diazepam47$453
Diclofenac Sodium11$429
Mirtazapine12$425
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen16$376
Oxycodone Hcl21$343
Cyclobenzaprine Hcl26$293
Methylphenidate Hcl14$263
Tamsulosin Hcl15$253

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Hummelstown

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →